Screener
Ocular Therapeutix OCUL Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Interest income | 6,050 | 3,826 |
| Interest expense | (2,777) | (2,984) |
| Change in fair value of derivative liabilities | 1,455 | (978) |
| Total other income (expense), net | 4,728 | (136) |
| Net loss | $(88,612) | $(64,053) |
| Net loss per share, basic | $(0.40) | $(0.38) |
| Weighted average common shares outstanding, basic | 224,099,410 | 169,396,989 |
| Net loss per share, diluted | $(0.40) | $(0.38) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ocular Therapeutix's other income (expense)?
- Ocular Therapeutix (OCUL) reported other income (expense) of $4.73M in Q1 2026.
- How has Ocular Therapeutix's other income (expense) changed year-over-year?
- Ocular Therapeutix's other income (expense) increased by 3576.5% year-over-year, from -$136K to $4.73M.
- What is the long-term trend for Ocular Therapeutix's other income (expense)?
- Over 2 years (2021 to 2025), Ocular Therapeutix's other income (expense) has grown at a -76.1% compound annual growth rate (CAGR), from $71.48M to $4.08M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Ocular Therapeutix's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude